Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a physician in the frame of a PASS study and described the occurrence of ileocolic intussusception in a 6-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject was under no other medication and had no relevant medical history nor allergy. Previous and/or concurrent vaccination included diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b vaccine; manufacturer unspecified; intramuscular; given on 5 November 2008; hepatitis B vaccine recombinant; manufacturer unspecified; intramuscular; given on 5 November 2008; influenza virus vaccine; manufacturer unspecified; intramuscular; given on 5 November 2008; live attenuated human rotavirus vaccine; GlaxoSmithKline; oral given on 2 July 2008. On 2 September 2008, the subject received 2nd dose of ROTARIX (oral), lot number not provided). On 11 November 2008, 70 days after vaccination with ROTARIX, the subject experienced rectal bleeding with mucus and gastroalimentary vomiting. On 12 November 2008, the subject was hospitalised. At admission, physical examination revealed pallor, abdominal distension with pain to the deep palpation, bowel sounds decreased and currant jelly stool. The abdominal ultrasound showed an intestinal obstruction and intussusception. Surgery was performed and ileocolic intussusception with appendicular ischemia was found and reduced by taxis. An appendectomy was also performed with a bad evolution. A second intestinal obstruction with multiple end to end anastomosis and dehiscent appendicular stump was diagnosed, leading to 2nd surgery on 19 November 2008. The events were resolved by anastomosis destruction, lysis and reconstruction of appendicular stump. The events were resolved by anastomosis destruction, lysis and reconstruction of appendicular stump. Intestinal resection was not performed. The subject was hospitalized for 22 days. The subject was treated with RANITIDINE, AMPICILLIN, amikacin and METAMIZOLE. On 3 December 2008, the events were resolved and the subject was discharged from hospital in good clinical condition. The physician considered the events were unrelated to vaccination with ROTARIX.
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166